


Healthcare News Roundup: Personne
HSMN NewsFeed - 21 Oct 2021
Austin L. Chiang, M.D., M.P.H. Joins Medtronic As Chief Medical Officer for Gastrointestinal Business
Austin L. Chiang, M.D., M.P.H. Joins Medtronic As Chief Medical Officer for Gastrointestinal Business
HSMN NewsFeed - 18 Oct 2021
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
HSMN NewsFeed - 12 Oct 2021
Andreas Tsukada Joins Caris Life Sciences as President of Japanese Operations and Head of International
Andreas Tsukada Joins Caris Life Sciences as President of Japanese Operations and Head of International
HSMN NewsFeed - 28 Sep 2021
ONO PHARMA USA Appoints David Trexler as Chief Commercial Officer to Strengthen U.S. Leadership
ONO PHARMA USA Appoints David Trexler as Chief Commercial Officer to Strengthen U.S. Leadership
HSMN NewsFeed - 21 Sep 2021
Dr. Milan Radovich, Ph.D., Joins Caris Life Sciences as Chief Precision Medicine Officer
Dr. Milan Radovich, Ph.D., Joins Caris Life Sciences as Chief Precision Medicine Officer
HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
HSMN NewsFeed - 13 Sep 2021
SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options
SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options
HSMN NewsFeed - 13 Sep 2021
ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer
ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer
HSMN NewsFeed - 8 Sep 2021
atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors
atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors
HSMN NewsFeed - 2 Sep 2021
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief Executive Officer
Chemomab Therapeutics Announces Appointment of Dale Pfost as Chief Executive Officer
